Annex Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Buy |
9,096
+309
| +4% | +$125K | 0.09% | 98 |
|
|
2025
Q1 | $4.37M | Sell |
8,787
-445
| -5% | -$221K | 0.12% | 92 |
|
|
2024
Q4 | $4.8M | Buy |
9,232
+660
| +8% | +$343K | 0.14% | 88 |
|
|
2024
Q3 | $5.3M | Buy |
8,572
+515
| +6% | +$319K | 0.17% | 83 |
|
|
2024
Q2 | $4.46M | Buy |
8,057
+138
| +2% | +$76.3K | 0.16% | 84 |
|
|
2024
Q1 | $4.6M | Sell |
7,919
-120
| -1% | -$69.7K | 0.16% | 82 |
|
|
2023
Q4 | $4.27M | Buy |
8,039
+861
| +12% | +$457K | 0.18% | 81 |
|
|
2023
Q3 | $3.63M | Buy |
7,178
+396
| +6% | +$200K | 0.22% | 76 |
|
|
2023
Q2 | $3.54M | Sell |
6,782
-649
| -9% | -$339K | 0.2% | 76 |
|
|
2023
Q1 | $4.28M | Sell |
7,431
-666
| -8% | -$384K | 0.23% | 64 |
|
|
2022
Q4 | $4.46M | Sell |
8,097
-6,638
| -45% | -$3.66M | 0.25% | 63 |
|
|
2022
Q3 | $7.47M | Sell |
14,735
-502
| -3% | -$255K | 0.5% | 34 |
|
|
2022
Q2 | $8.28M | Buy |
15,237
+397
| +3% | +$216K | 0.6% | 28 |
|
|
2022
Q1 | $8.77M | Buy |
14,840
+820
| +6% | +$484K | 0.64% | 26 |
|
|
2021
Q4 | $9.36M | Buy |
14,020
+196
| +1% | +$131K | 0.64% | 25 |
|
|
2021
Q3 | $7.9M | Buy |
13,824
+93
| +0.7% | +$53.1K | 0.65% | 21 |
|
|
2021
Q2 | $6.97M | Buy |
13,731
+2,819
| +26% | +$1.43M | 0.56% | 22 |
|
|
2021
Q1 | $4.98M | Sell |
10,912
-552
| -5% | -$252K | 0.48% | 31 |
|
|
2020
Q4 | $5.34M | Buy |
+11,464
| New | +$5.34M | 0.52% | 24 |
|